Modelling costs of interventional pulmonary embolism treatment: implications of US trends for a European healthcare system.
Katharina MohrBrent KeelingKlaus KaierThomas NeusiusRachel P RosovskyJohn M MoriartyKenneth R RosenfieldChristina AbeleIoannis T FarmakisKarsten KellerAlexandru GrigoreanRichard N ChannickJay S GiriRobert A LooksteinThomas M TodoranKonstantinos C ChristodoulouLukas HobohmMichelle LannoJamie ReedHarald BinderStavros V KonstantinidesLuca ValerioEric A SecemskyPublished in: European heart journal. Acute cardiovascular care (2024)
Our approach and results, which may be adapted to other European healthcare systems, provide a benchmark for healthcare costs expected to result from CDT. Data from ongoing trials on clinical benefits and cost savings are needed to determine cost-effectiveness and inform reimbursement decisions.